Home › Sjögren's Disease › New Jersey › Edison
Sjögren's Disease clinical trials in Edison, NJ
3 studies for Sjögren's Disease are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- Arthritis Rheumatology and Bone Disease Associates PA, Voorhees Township · 5 mi away
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Arthritis, Rheumatic & Bone Disease Associates - Voorhees, Voorhees Township · 5 mi away
About Sjögren's Disease
Sjögren's disease is an autoimmune disease that causes dryness of the mouth, eyes, and other parts of the body. Learn how to relieve the symptoms.
More about Sjögren's Disease on MedlinePlus
Sjögren's Disease trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Tampa, FL4 studies
- Clearwater, FL4 studies
- Cicero, IL4 studies
- Arlington, TX4 studies
- Charlotte, NC4 studies
- Oklahoma City, OK3 studies
- Memphis, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
Other studies in Edison
- Breast Cancer70 studies
- Non-Small Cell Lung Cancer50 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer25 studies
- Lung Cancer25 studies
- Bladder Cancer23 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Ovarian Cancer19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.